Risk assessment of chemical carcinogens and thresholds

Critical Reviews in Toxicology

Volumn 39, Issue 6, 2009, Pages 449-461

  Neumann, Hans Günter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

ALARA principle; Aromatic amines; Chemical carcinogens; Dose response relationship; Initiation promotion; Risk assessment; Threshold

Indexed keywords

4 DIMETHYLAMINOSTILBENE; CARCINOGEN; DNA; N (2 FLUORENYL)ACETAMIDE; RNA; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; BINDING AFFINITY; CANCER INCIDENCE; CANCER RISK; CONCENTRATION RESPONSE; GENOTOXICITY; HUMAN; MAXIMUM ALLOWABLE CONCENTRATION; METABOLISM; NONHUMAN; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; HUMANS; RISK ASSESSMENT; THRESHOLD LIMIT VALUES;

EID: 70350517581     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.1080/10408440902810329     Document Type: Review

References (79)

1. American Conference of Governmental Hygenist. (2004). TLVs and BEIs. Treshold Limit Values and Biological Exposure Indices. ACGIH, Cincinnaty, USA. American Industrial Health Council. (1981). Annual newsletter
2. Aldridge, W.N. (1995). Defning thresholds in occupational and environmental toxicity. Toxicol. Lett. 77: 109-118
3. Bernheim, N.J., and Falk, H. (1981). Chemical, physical and genetic factors interfering with DNA repair-A review. J. Am. Coll. Toxicol. 2: 23-54
4. Bitsch, A., Deubelbeiss, C., and Greiner, A. (1999). c-fos gene expression in rat liver is induced by phenobarbital. Cancer Lett. 135: 215-1122
5. Bitsch, A., Hadjiolov, N., Klöhn, P.C., Bergmann, O., Zwirner-Baier, I., and Neumann, H.G. (2000). Dose-response of early efects related to tumor promotion of 2-acetylaminofuorene. Toxicol. Sci. 55: 44-51
6. Bridges, B.A., and Stamper, J.G. (1975). Hypothetical Dose-response curves for chronic exposures to mutagens or carcinogens subject to simple enzymatic detoxifcation in the mammalian body. Mutat. Res. 33:87-91
7. Broccardo, C.J., Billings, R.E., Chubb, L.S., Andersen, M.E., and Hannemann, W.H. (2004). Single Cell analysis of switch-like induction of CYP1A1 in liver cell lines. Toxicol. Sci. 78:287-294
8. Burnet, F.M. (1976). Mutation, somatische Mutation und Krankheit beim Menschen. Naturw. Rdsch. 29: 305-311
9. Butterworth, B.E., and Bogdanfy, M.S. (1999). A comprehensive approach for integration of toxicity and cancer risk assessment. Regul. Toxicol. Pharmacol. 29:23-36
10. Claus, G. (1974). Environmental carcinogenesis; Is there a threshold of exposure. Clin. Toxicol. 7: 497-508
11. Claus, G., Krisko, I., and Bolander, K. (1974). Chemical carcinogens in the environment and the human diet: Can a threshold be established. Food Cosmet. Toxicol. 12: 737-746
12. Clayson, D.B. (1978). Overview, myth and speculation. J. Environ. Pathol. Toxicol. 2:1-8
13. Cox, C. (1987). Treshold dose-response models in toxicology. Biometrics 43: 511-523
14. Crump, K.S., Hoel, D.G., Langley, C.H., and Peto, R. (1976). Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Res. 36: 2973-2979
15. Diaz Gomez, M.I., Swann, P.F., and Magee, P. (1977). Te absorption and metabolism in rats of small oral doses of dimethylnitrosoamine. Biochem. J. 164: 497-500
16. Druckrey, H. (1943). Quantitative Grundlagen der Krebserzeugung. Klin. Wochenschrift 22: 532-534
17. Druckrey, H. (1959). Pharmacological approach to carcinogenesis. In: Ciba Foundation Symposium on Carcinogenesis, Mechanisms of Action, Wolstenholm G.E.W., ÓConnor M (Hrsg.), L&A Churchill Ltd. Gloucester, Great Britain, pp. 110-130
18. Druckrey, H., Schmähl. D., Dischler, W., and Schildbach, A. (1962). Quantitative Analyse der experimentellen Krebserzeugung. Naturwissenschaften 49: 217-228
19. Dunn, B.P. (1983). Wide range linear dose-response curve for DNA binding of orally administered benzo(a)pyrene in mice. Cancer Res. 43:2654-2658
20. Edler, L., Porti, C.J., and Kopp-Schneider, A. (1994). Zur Existenz von Schwellenwerten: Wissenschaftliche Methode oder statistisches Artefakt in der Risikoabschätzung. Zbl. Arbeitsmed. 44: 16-21
21. EU-Bericht v. 26.10. (2000). First Report on the Harmonisation of Risk Assessment Procedures. 2. Appendices
22. Farmer, J.H., Kodell, R.L., Greenman, D.L., and Shaw, G.W. (1979). Dose and time response models for the incidence of bladder and liver neoplasms in mice fed 2-acetylaminofuorene continuously. J. Environ. Pathol. Toxicol. 3: 55-68
23. Hanahan, D., and Weinberg, R.A. (2000). Te hallmarks of cancer. Cell 100: 57-70
24. Hart, R.W., and Frame, L.T. (1996). Toxicological defense mechanism and how they may afect the nature of dose-response relationships. Belle Newslett. 5:1-16
25. Haseman, J.K. (2003). An alternative perspective: a critical evaluation of the Waddell threshold extrapolation model in chemical carcinogenesis. Toxicol. Pathol. 31: 712-713
26. HBM-Kommission, Stellungnahme. (2003). Verwendung von Hämoglo-binaddukten als Biomarker für das Monitoring von Belastungen und Beanspruchungen durch gentoxische Stofe. Bundesgesund. Gesundheits. Gesundheitsschutz. 46: 918-922
27. Hecker, E., and Rippman, F. (1988). Quantitative determination of experimental threshold doses (no-efect levels) for environmental promoters in the initiation/promotion protocol on skin of NRMI mice. Naunyn-Schmiedebergs Arch. Pharmacol. 338(Suppl. R11)
28. Henschler, D. (1973a). Veränderungen der Umwelt-Toxikologische Probleme. Angew. Chem. 85: 317-326
29. Henschler, D. (1973b), Toxicological problems relating to changes in the environment. Angew. Chem. Int. Ed. Engl. 12: 274-282
30. Henschler, D. (1974). New approaches to a defnition of threshold values for irreversible efects. Arch. Toxicol. 32: 63-67
31. Hooper, N.K., Harris, R.H., and Ames, B.N. (1979). Letters. Chemical carcinogens. Science 203: 602-603
32. Ito, N., Imaida, K., Hasegawa, R., and Tsuda, H. (1988) Enhancing efect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats-An approach for a new medium-term bioassay system. Carcinogenesis 9: 387-394
33. Jackson, C.D., Weis, C., and Shellenberger, T.E. (1980). Tissue binding of 2-acetylaminofuorene in BALB/c and C57Bl/6 mice during chronic oral administration. Chem. Biol. Interact. 32: 63-81
34. Kisch-Volders, M., Aaredema, M., and Elhajoiji, A. (2000). Concepts of thresholds in mutagenesis and carcinogenesis. Mutat. Res. 464:3-11
35. Kitano, M., Ichihara, T., Matsuda, T., Wanibuchi, H., Tamano, S., Hagiwara, A., Imaoka, S., Funae, Y., Shirai, T., and Fukushoma, S. (1998). Presence of a threshold for promoting efects of phenobarbital on diethylnitrosamine-induced hepatic foci in the rat. Carcinogenesis 19: 1475-1480
36. Klöhn, P.C., Bitsch, A., and Neumann, H.G. (1998). Mitochondrial permeability transition is altered in early stages of carcinogenesis of 2-acetylaminofuorene. Carcinogenesis 19: 1185-1190
37. Koelle, G.B. (1977). Te zero-tolerance concept. Perspect. Biol. Med. 20: 507-509
38. Kunz, H.W., Tennekes, H.A., Port, R.E., Schwartz, M., Lorke, D., and Schaude, O. (1983). Quantitative aspects of chemical carcinogenesis and tumor promotion in liver. Environ. Health Perspect. 50: 113-122
39. Lewalter, J., and Neumann, H.G. (1998). Background exposure of persons not occupationaly exposed to chemicals, in: Deutsche Forschungsgemeinschaft, Greim, H., Lehnert, G., (edts.), Biological exposure values for occupational toxicants and carcinogens, Vol.3. Wiley-VCH, Weinheim, pp. 3-34
40. Lutz, W.K., and Fekete, T. (1996). Endogenous and exogenous factors in carcinogenesis: Limits to cancer prevention. Int. Arch. Occup. Environ. Health 68: 120-125
41. Lutz, W.K., and Gaylor, D. (1996). Signifcance of DNA adducts at low dose: Shortening the time to spontaneous tumor occurrence. Regul. Toxicol. Pharmacol. 23: 29-34
42. Lutz, W.K., and Kopp-Schneider, A. (1999). Treshold dose response for tumor induction by genotoxic carcinogens modeled via cell-cycle delay. Toxicol. Sci. 49: 110-115
43. Lutz, W.K., Beland, P.E., Candrian, R., Fekete, T., and Fischer, W.H. (1996). Dose-time response in mouse skin tumor induction by 7,12-dimethylbenz(a) anthracene and 12-O-tetradecanoyl-phorbol 13-acetate. Regul. Toxicol. Pharmacol. 23: 44-48
44. Lutz, W.K., and Schlatter, C. (1978). Extrapolation of carcinogenicity data to low doses with a dose-response study of the binding of benzo(a)pyrene to rat liver DNA. Arch. Toxicol. Suppl 1: 369-371
45. MAK-und BAT-Werte-Liste. (2004). Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstofe, DFG. Wiley-Verlag, Weinheim
46. Mantel, N., and Schneiderman, M.A. (1975). Estimating "safe" levels, A hazardous undertaking. Cancer Res. 35: 1379-1386
47. Mastromatteo, E. (1981). On the concept of threshold. Am. Ind. Hyg. Assoc. J. 42: 763-770
48. Maugh, T.H. II. (1978). Chemical carcinogens: How dangerous are low doses. Science 202: 37-41
49. Miller, J.A., and Miller, E.C. (1971). Chemical carcinogenesis: Mechanisms and approaches to its control. Guest editorial. J. Natl. Cancer Inst. 47: V-XIV.
50. Montesano, R. (1981). Alkylation of DNA and tissue specifcity in nitrosamne carcinogenesis. J. Supramol. Structure Cell.Biochem. 17: 259-273
51. Neumann, H.G. (1973). Ultimale elektrophile Carcinogene und nukleophile Reaktanten der Zelle. Vortrag: 14, Frühjahrstagung der DGPT, 18.-21.3. Mainz.
52. Neumann, H.G. (1974). Ultimate electrophillic carcinogens and cellular nucleophilic reactants. Arch. Toxicol. 32: 27-38
53. Neumann, H.G., Baur, H., and Wirsing, R. (1980). Dose-response relationship in the primary lesion of strong electrophilic carcinogens. In: Quantitative aspects of risk assessment in chemical carcinogenesis. Arch. Toxicol. Suppl. 3: 69-77, discussion 145-147
54. Oesch, F., Herrero, M.E., Hengstler, J.G., Lohmann, M., and Arand, M. (2000). Metabolic detoxifcation; implications for thresholds. Toxicol. Pathol. 28: 382-387
55. Park, C.N., and Snee, E.D. (1983). Quantitative risk assessment: State of the art for carcinogenesis. Fundam. Appl. Toxicol. 3: 320-333
56. Paynter, O.E., Burin, G.J., Jaeger, R.B., and Gregorio, C.A. (1988). Goitrogens and thyroid follicular cell neoplasia: Evidence for a threshold process. Regul. Toxicol. Pharmacol. 8: 102-119
57. Pitot, H.C., and Campbell, H.A. (1988). Quantitative studies on multistage hepatocarcinogenesis in the rat. In: Langenbach, R. et al. (edts.), Tumor promoters: Biological approaches for mechanistic studies and assay systems. Raven Press, New York, pp. 79-95
58. Poirier, M.C., Fullerton, N.F., Kinouchi, T., Smith, B.A., and Beland, F.A. (1991). Comparison between DNA adduct formation and tumorigenicity in livers and bladders of mice chronically fed 2-acetylaminofuorene. Carcinogenesis 12: 895-900
59. Pong, R.S., and Wogan, G.N. (1970). Time course and dose-response characteristics of afatoxin B1 Efects on rat liver DNA polymerase and ultrastructure. Cancer Res. 30: 294-304
60. Ramsey, J.C., and Gehring, P.J. (1980). Application of pharmacokinetic principles in practice. Fed. Proc. 39: 60-65
61. Risiko Kommission. (2003). Ad Hoc Kommission"Neuordnung der Verfahren und Strukturen zur Risikobewertung und Standardsetzung im gesundheitlichen Umweltschutz in der Bundesrepublik Deutschland." Abschlussbericht 2003
62. Roach, S.A., and Rappaport, S.M. (1990). But they are not thresholds: A critical analysis of the documentation of threshold limit values. Am. J. Ind. Med. 17: 727-753
63. Rozman, K.K. (2003). Tresholds in carcinogenicity in EDO1 study. Toxicol. Sci. 75: 224-225
64. Schaefer, D. (1983). Tresholds for carcinogenesis and their signifcance to medical practice. Med. Hypoth. 10: 175-184
65. Schneiderman, M.A., and Brown, C.C. (1978). Estimating cancer risk to a population. Environ. Health Perspect. 22: 115-124
66. Schulte-Hermann, R., Grassl-Kraupp, B., and Bursch, W. (2000). Dose-response and threshold efects in cytotoxicity and apoptosis. Mutat. Res. 464: 13-18
67. Science and Judgment. (1994). National Research Council, National Academy Press, Washington, DC
68. Scott-Appleton, B., Goetchius, M.P., and Campbell, T.C. (1982). Linear dose-response curve for the hepatic macromolecular binding of afatoxin B1 in rats at very low exposures. Cancer Res. 42: 3659-3662
69. Seiler, J.P. (1977). Apparent and real thresholds. Progress in genetic toxicology. Elsevier/North Holland Biomedical Press, Amsterdam, pp. 233-238
70. Stockinger, H.E. (1972). Concepts of thresholds in standards setting. Arch. Environ. Health 25: 153-157
71. Swarts, J.B., Riddlough, C.R., and Epstein, S.S. (1982). Analysis of carcinogenic dose-response relations with dichotomous data: Implications for carcinogenic risk assessment. Teratogen. Carcinogen. Mutagen. 2:179-204
72. Travis, C.C., Zeng, C., and Nicholas, J. (1996). Biological model of ED01 hepatocarcinogenesis. Toxicol. Appl. Pharmacol. 140: 19-29
73. Tritscher, A.M., Goldstein, J.A., Portier, C.J., McCoy, Z., Clark, G.C., and Lucier, G.W. (1992). Dose response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: Quantifcation and immunolocalisation of CYP1A1 and CYP1A2 in the liver. Cancer Res. 52: 3436-3442
74. Waddell, W.J. (2003). Tesholds of carcinogenicity in the EDO1 study. Toxicol. Sci. 72:158-163
75. Williams, G.M. (1987). Defnition of a human cancer hazard. In: Butterworth, B.E., and Slaga, T. (edts.), Nongenotoxic mechanisms in carcinogenesis, 25th Banbury Report, Cold Spring Harbor Laboratory, Cold Spring Harbor, N Y. Wolf, F.J. (1980). Efect of overloading pathways on toxicity. J. Environ. Pathol. Toxicol. 3: 113-134
76. Yamasaki, H. (1988). Multistage carcinogenesis: Implications for risk estimation. Cancer Metastasis Rev. 7: 5-18
77. Yamasaki, H., and Weinstein, L.B. (1982). Cellular and molecular mechanisms of tumor promotion and their implications with respect to risk assessment. SGCMSEC Workshop on qnantitative estimation of risk to human health from chemicals, in Rome. Cf. Vouk, V.B., Hoel, G.C., and Peakall, D.B. (edts.), Methods for estimating risk of chemical injury: Human and non-human biota and ecosystems. John Wiley, New York, 1985, pp. 155-180
78. Zeise, L., Wilson, R., and Crouch, E.A.C. (1987). Dose-response relationships for carcinogens: A review. Environ. Health Perspect. 73: 259-308
79. Zerban, H., Preussmann, R., and Bannasch, P. (1988). Dose-time relationship of the development of preneoplastic liver lesions induced in rats with low doses of N-nitrosodiethylnolamine. Carcinogenesis 9: 607-610